Results 251 to 260 of about 102,092 (268)

The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

Clinical Pharmacology and Therapeutics, 2011
Jörg Huwyler
exaly  

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

Social Neuroscience, 2009
Rogier Donders
exaly  

Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others

Biological Psychiatry, 2010
Gillinder Bedi, Harriet de Wit
exaly  

Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene

International Journal of Drug Policy, 2017
Joseph J Palamar, Alberto Salomone, Enrico Gerace   +2 more
exaly  

Ecstasy

2019
openaire   +2 more sources

Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats

British Journal of Pharmacology, 2011
exaly  

Ecstasis

2017
openaire   +1 more source

Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users

Neuroscience and Biobehavioral Reviews, 2016
Carl Roberts, Andrew Jones, Catharine Montgomery   +2 more
exaly  

MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users

Neuroscience and Biobehavioral Reviews, 2013
exaly  

Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management

British Journal of Anaesthesia, 2006
exaly